81%
Infection
Reduction.
Nozin IP Programs
™
y
Address pre-op and post-op SSI risk
y
Can include use by staff, caregivers
y
No antibiotics. No iodine.
y
Safely reduce contact precautions
for MRSA colonization
1
Existing Bundle for
Infection Prevention
I
N
F
E
C
T
I
O
N
R
A
T
E
with Nozin
®
added
81%
SSI reduced
Watch testimonial at Nozin.com
NASAL DECOLONIZATION
IS THE KEY
Nozin.com 877-669-4648
To contact your Nozin advisor
and for professional samples:
LEADER IN NASAL DECOLONIZATION
™
1. Mullen A, et al. AJIC, 2017: 45(8): 554-6 2. Deatherage N. AJIC, 2016: 44:(6):S101-S102. 3. Steed L, et al. AJIC, 2014: 42(8): 841-846. ©2018 Global Life Technologies Corp. All rights
reserved. Made in USA. Nozin®, Nasal Sanitizer®, 360™, Leader in nasal decolonization™, are trademarks of Global Life Technologies Corp. Nozin® Nasal Sanitizer® antiseptic is an OTC
topical drug. No claim is made that it has an effect on any specific disease.
Nasal S. aureus is a major risk factor for HAI. Nozin Infection
Prevention (IP) Programs deliver patient nasal decolonization
pre-op through post-op recovery as well as offer Nozin use
by staff and caregivers. This 360™ protection is shown to
help reduce surgical site infection (SSI) significantly.
1
Nozin programs also utilize patient decolonization to help
safely reduce costly contact precautions (CP) for MRSA
colonization.
2
The alcohol-based Nozin® Nasal Sanitizer®
antiseptic is proven to decolonize nasal S. aureus day one.
3
Learn more about how Nozin can be key to improving care.
